Glen Wheeler
About Glen Wheeler
Glen Wheeler is a Principle Engineer at Alkermes in Dublin, Ireland, with extensive experience in pharmaceutical manufacturing and drug development.
Title and Current Position
Glen Wheeler is currently a Principle Engineer at Alkermes, based in Dublin, Ireland. He has held this role since June 2002, contributing to the development of innovative medicines for central nervous system (CNS) diseases.
Professional Experience
Before joining Alkermes, Glen Wheeler accumulated extensive experience in the pharmaceutical industry. He worked at Eli Lilly and Company as a Senior Process Development Engineer from 1999 to 2002 in Indianapolis, Indiana. Prior to that, he served as a Technical Services Representative at the same company from 1995 to 1999. Additionally, Wheeler worked as an Organic Chemist at Isotec in Lawrenceville, New Jersey, from 1990 to 1992.
Educational Background
Glen Wheeler holds multiple degrees in science and business. He earned a Master of Business Administration (MBA) in Logistics from Fisher College between 2007 and 2009. He also attained a Master of Science in Chemical Engineering from The Ohio State University, studying from 1992 to 1995. Additionally, Wheeler possesses a Bachelor of Science in Chemistry from Wilmington College, obtained between 1986 and 1990.
Expertise and Skills
Glen Wheeler has a robust background in developing novel manufacturing processes for small molecule pharmaceuticals and biodegradable polymers. His comprehensive experience spans across drug development activities, including non-clinical, clinical, active pharmaceutical ingredients (API), and sterile injectables. Wheeler's balanced approach to leadership combines emotional intelligence with business acumen, making him an invaluable asset in his field.
Contributions at Alkermes
Since joining Alkermes in 2002, Glen Wheeler has significantly influenced the company's efforts in CNS disease treatment. His work has supported a diversified commercial product portfolio and an extensive clinical pipeline aimed at treating chronic conditions such as schizophrenia, depression, addiction, and multiple sclerosis.